Alopecia Areata Clinical Trials in Michigan

Home | Studies | Alopecia Areata

Hiding Hair Loss is Not the Solution

Participate in Alopecia Areata Clinical Trials!

Alopecia Areata is an autoimmune condition where the immune system erroneously attacks hair follicles, leading to hair loss in small, round patches on the scalp. It is a condition that affects both men and women. Moreover, it can also occur in other hair-bearing areas of the body. Having hair loss can affect one’s self-esteem and causes much anxiety. However, there is a potential treatment for Alopecia Areata to address this condition.

Revival Research Institute is carrying out Alopecia Areata Clinical Trials in Michigan. The clinical trial for hair loss aims to study the safety and efficacy of an investigational drug that could potentially help people with hair loss.

You may be eligible for the Alopecia Areata Clinical Trials in Michigan if you are:

Aged 18 years or older
Suffering hair loss in small or round patches

We are conducting phase 2 Alopecia Areata Clinical Trials for hair loss. This could be a potential breakthrough against hair loss.
*To participate in the Alopecia Areata Clinical Trials, please fill out the form, and someone from our research team will give you a call.
**The study drug and study-related care will be provided at no cost. No insurance is required to participate.

*Who is this information for?

A Family Member

A Friend

My Patient

Please provide YOUR contact information only.

First Name

Last Name

Phone

Confirm Phone

Best time to call?

Morning

Middle of the day

Evening

State

How did you hear about us?*

Comments

User Agreement*

By Signing up, I agree to be contacted via calls and SMS.

About Alopecia Areata Clinical Trials: Investigating Potential Treatment for Hair Loss

Revival Research Institute is conducting a Phase 2 Alopecia Areata Clinical Trial. This study lasts 40 weeks, which will help us learn if the investigational drug is safe and effective in reducing hair loss. The goal of the Alopecia Areata Clinical Trials in Michigan is to observe whether the drug can help stop hair loss in people and improve their condition.

The investigational drug may help with hair regrowth by binding it to the receptors that result in hair loss. If you are eligible to participate in the Alopecia Areata Clinical Trial and decide to take part, you might receive the study drug or placebo.

*Participating in the Alopecia Areata Clinical Trials in Michigan is completely voluntary. You can discontinue or stop taking part at any time.

*There will be other study requirements the study team will discuss with you if you participate in this study.

Get Started: What to Expect?

If you meet the study criteria for potential treatment for Alopecia Areata in Michigan, you will be randomly assigned to one of two groups. One of the groups will receive the investigational Alopecia Areata study drug. The other group will receive a matching placebo. Every participant will have an equal chance of receiving the investigational drug or the placebo. As this is a double-blind research study, neither you nor the research team will know who gets to receive the study drug.

After you fill out the form above, someone from our research will give you a call. If you fit the Alopecia Areata Clinical Trials in Michigan eligibility criteria, you might be invited to the study site’s location. Before you decide to participate, our study team will brief you on all details about participating in the clinical trial, including the risks and benefits. Throughout the study, the research team will monitor your condition and look for any adverse or severely adverse effects.

Condition

Alopecia Areata

Length of Study

10 Months

Number of Study Visits

Approx. 17 visits

About Alopecia Areata

Alopecia is the medical term for hair loss, while alopecia areata specifically refers to a type of hair loss characterized by sudden, patchy bald spots on the scalp or other parts of the body. Alopecia areata can occur both in males and females as well. The alopecia most commonly observed in men is known as Androgenic Alopecia.

Most of the individuals with this condition are healthy and have no other symptoms. However, it varies from person to person. Few of the individuals have bouts of hair loss throughout their entire lives, while others may only face a single episode. Alopecia areata is seen to begin with sudden loss of round or oval patches mainly on the scalp, but it can also affect other areas such as beard in men, or the eyelashes or eyebrows in both. It results in visible patches of baldness but the most noticeable damage it does is to one’s self-image and confidence which is why Revival Research Institute is carrying out Clinical Trials for Alopecia Areata.

Frequently Asked Questions

What is Alopecia Areata?

Alopecia areata is an autoimmune condition where the immune system mistakenly attacks hair follicles, leading to hair loss in small, round patches on the scalp. It is a prevalent condition that affects both men and women. Moreover, it can also occur in other hair-bearing areas of the body.

What causes Alopecia Areata?

Alopecia areata is marked by an inflammatory process, though its exact pathophysiology is not fully understood. This lack of clarity is why clinical research is essential, helping researchers and doctors gain a deeper understanding of the condition. It is believed that the development of alopecia areata is influenced by both genetic predisposition and environmental factors, such as exposure to toxic agents.

Does stress contribute to Alopecia Areata?

There are various factors that contribute to alopecia areata, including the potential influence of stress. In this condition, the body’s immune system targets hair follicles, which further leads to hair loss.

Who can enroll in Alopecia Areata Clinical Trials in Michigan?

Healthy individuals who are above the age of 18 years and suffer from hair loss in small or round patches on the scalp or other hair-bearing areas of the body are eligible to enroll. Participants should be willing to maintain the same hairstyle, hair length, hair color, hair care products like shampoo, and habits throughout the potential treatment for alopecia areata. When you contact the study team, they will let you know of additional participation criteria.

Is Alopecia Areata treatable?

Enrolling in Alopecia Areata Clinical Trials that is investigating potential treatments for alopecia areata, may offer the opportunity to explore effective solutions and help you potentially regain confidence and hair growth.

What are the types of Alopecia Areata?

Three main types of Alopecia Areata are:

Patchy Alopecia Areata: In this type, hair loss occurs in coin-sized patches on the scalp or other parts of the body.
Alopecia Totalis: In this type of alopecia areata, there is loss of entire or nearly all hair on the scalp.
Alopecia Universalis: In this kind, there is complete or almost loss of hair on the scalp, face, and rest of the body.

Will I be compensated for my time and travel in the Alopecia Areata Clinical Trials for hair loss?

If you are eligible and decide to participate in the Alopecia Areata Clinical Trials in Michigan, you will receive reimbursement for your time and travel. The study drug and any study-related procedures will be provided to you at no cost.